Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/66359
標題: 中部地區豬胸膜肺炎放線桿菌抗藥性及血清型研究
Investigation of antimicrobial resistance and serotyping of Actinobacillus pleuropneumoniae in central Taiwan
作者: 謝一美
Hsieh, Yi-Mei
關鍵字: actinobacillus pleuropneumoniae;豬胸膜肺炎放線桿菌;antimicrobial resistance;serotyping;抗藥性;血清型
出版社: 獸醫公共衛生學研究所
引用: 洗琼珍。APP分離培養、鑑定、分型及雙價滅活苗免疫研究。碩士論文。湖南農業大學。2005。 徐興鎔、翁仲男、周凝元、金約翰、韓海倫。豬嗜血桿菌肺炎在台灣之流行報告。台糖畜產研究所64/65年期研究試驗報告。191-197。1976。 徐興鎔、葉哲明、沈詠梅、周凝元。豬嗜血桿菌胸膜肺炎之研究:流行病學血清型別與藥物敏感性之研究。台糖畜產研究所73/74年期研究試驗報告。127-132。1985。 張甘楠。胸膜肺炎放線桿菌第一血清型之質體與其抗藥性之研究。中華獸醫誌。22(2)。129-135。1996。 蔡信雄。 96年度豬場獸醫師訓練班講義。 財團法人台灣動物科技研究所。 48-63。 2007。 鄭雅芬。豬胸膜肺炎放線桿菌多型細胞之定性。碩士論文。中興大學。獸醫學研究所。台中。台灣。1994。 Aarestrup FM, and Jensen NE. Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark. Evaluation of three different media of MIC-determinations and tablet diffusion tests. Vet Microbiol 64: 299–305, 1999. Aarestrup FM. Monitoring of Antimicrobial Resistance Among Food Animals: Principles and Limitations. J Vet Med Series 51: 380-388(9), 2004. Abul-Milh M, Paradis SE, Dubreuil JD, and Jacques M. Binding of Actinobacillus pleuropneumoniae lipopolysaccharides to glycosphingolipids evaluated by thin-layer chromatography. Infect Immun 67: 4983–4987, 1999. Albert MJ, Kibriya AK, and Tzipori S. Reliability of colony characteristics on MacConkey agar to identify Escherichia coli for epidemiological investigations. J Diarrhoeal Dis Res 8: 166-167, 1990. Anderson C, Potter AA, and Gerlach GF. Isolation and molecular characterization of spontaneously occurring cytolysin-negative mutants of Actinobacillus pleuropneumoniae serotype 7. Infect Immun 59: 4110-4116, 1991. Anderson MD, and Williams JA. Effects of tiamuline base administered intramuscularly to pigs for treatment of pneumonia associated with Actinobacillus (Haemophilus) pleuropneumoniae. Proc Int Pig Vet Soc Congr 11: 15, 1990. Angen Ø, Ahrens P, and Jessing SG. Development of a multiplex PCR test for identification of Actinobacillus pleuropneumoniae serovars 1, 7, and 12. Vet Microbiol doi: 10.1016/j.vetmic.2008.05.010, 2008. Asawa T, Kobayashi H, Mitani K, Ito N, and Morozumi T. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from piglets with pleuropneumoniae. J Vet Med Sci 57: 757-759, 1995. Assavacheep P, Persson M, Luengyosluechakul S, Watanaphansak S, Laohasinnarong D, Pungkhun P, and Wallgren P. Actinobacillus pleuropneumoniae in Thai Pig Herds. Prevalence of Serum Antibodies and Relation to Performance. J Vet Med B 50: 390–395, 2003. Bandara AB, Lawrence ML, Veit HP, and Inzana TJ. Association of Actinobacillus pleuropneumoniae capsular polysaccharide with virulence in pigs. Infect Immun 71: 3320-3328, 2003. Barness S, Franklin J, and Tabaqchali S. The successful treatment of multiresistant non-enteric salmonellosis with seven day oral ciprofloxacin. J Antimicrob Chemother 25: 299-300, 1990. Beck M, van den Bosch JF, Jongenelen IM, Loeffen PL, Nielsen R, Nicolet J, and Frey J. RTX toxin genotypes and phenotypes in Actinobacillus pleuropneumoniae field strains. J Clin Microbiol 32: 2749-2754, 1994. Belanger M, Begin C, and Jacques M. Lipopolysaccharides of Actinobacillus pleuropneumoniae bind pig hemoglobin. Infect. Immun. 63: 656-662, 1995. Bertram TA. Pathobiology of acute pulmonary lesions in swine infected with Haemophilus(Actinobacillus) pleuropneumoniae. Can Vet J 29: 574-577, 1988. Bertram TA. Quantitative morphology of peracute pulmonary lesions in swine induced by Haemophilus pleuropneumoniae. Vet Pathol 22: 598-609, 1985. Bilinski T. Oxygen toxicity and microbial evolution. Biosystems 24: 305-312, 1991. Blackall PJ, Klaasen HI, van den Bosch H, Kuhnert P, and Frey J. Proposal of a new serovar of Actinobacillus pleuropneumoniae serovar 15. Vet Microbial 84: 47-52, 2002. Blackburn CW and McCarthy JD. Modefications to methods for the enumeration and detection of injured Escherichia coli O157:H7 in foods. Int J Food Microbiol 55: 285-290, 2000. Blanco M, Gutierrez-Martin CB, Rodriguez-Ferrin EF, Roberts MC, and Navas J. Distribution of tetracycline resistance genes in Actinobacillus pleuropneumoniae isolates from Spain. Antimicrob Agents Chemother 50: 702-8, 2006. Boekema BKHL, Kamp EM, Smits MA, Smith HE, and Stockhofe-Zurwieden N. Both ApxⅠand ApxⅡof Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence. Vet Microbiol 100: 17-23, 2004. Bosse JT, Gilmour HD, and MacInnes JI. Novel genes affecting urease activity in Actinobacillus pleuropneumoniae, J Bacteriol 183: 1242-1247, 2001. Bosse JT, Janson BJ, Sheehan A J, Beddek AN, and Rycroft JS. Kroll, and P. R. Langford. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect 4: 225-235, 2002. Broes A, Martineau GP, and Gottschalk M. Dealing with unexpected Actinobacillus pleuropneumoniae serological results. J Swine Health Prod 15(5): 264-269, 2007. Burton PJ, Thornsberry C, Yee YC, Watts JL, and Yancy, Jr RJ. Intepretive criteria for antimicrobial susceptibility testiing of ceftiofur against bacteria associated with swine respiratory disease. J Vet Diagn Invest 8: 464-468, 1996. Chamberlain JS, Gibbs RA, Ranier JE, and Caskey CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy, In M. Innis, D. Gelfand, J. Sninski, and T. White ( ed.), PCR protocols : a guide to methods and applications. Academic Press Orlando Fla 272-281, 1990. Chamberlain JS, Gibbs RA, Ranier JE, and Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16: 11141-11156, 1988. Chang CF, Chang LC, Chang YF, Chen M, Chiang TS. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Escherichia coli, and Salmonella choleraesuis recovered from Taiwanese swine. J Vet Diagn Invest 14: 153-157, 2002a. Chang CF, Yeh TM, Chou CC, Chang YF, and Chiang TS. Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan. Vet Microbiol 84: 169-177, 2002b. Chang CN, Shen YM, and Yu PH. Epidemiology of swine haemophilus pleuropneumoniae. Bull Inst Taiwan Sugar Co, pp.139-147, 1990. Chang SC, Chen YC, and Hu OY. Antibiotic use in public hospitals in Taiwan after the implementation of National Health Insurance. J Formos Med Assoc 100: 155-61, 2001. Chatellier S, Harel J, Dugourd D, Chevallier B, Kobisch M, and Gottschalk M. Genomic relatedness among Actinobacillus pleuropneumoniae field stranis of serotypes 1 and 5 isolated from healthy and diseased pigs. Can J Vet Res 63: 170-6, 1999. Chen FJ, Lo HJ. Molecular mechanisms of fluoroquinolone resistance. J Microbiol Immunol Infect 36: 1-9, 2003. Chen FJ, McDonald LC, Ho M, Lo HJ. Identification of fluoroquinolone reduced-susceptibility in Escherichia coli: a herald for emerging resistance. J Antimicrob Chemother 48:936-938, 2001. Chen YT, Shu HY, Li LH, Liso TL, Wu KM, Shiau YR, Yan JJ, Su IJ, Tsai SF, and Lauderdale TL. Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in clinical Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 50: 3861-3866, 2006. Chiers K, Donné E, Van Overbeke I, Ducatelle R, and Haesebrouck F. Actinobacillus pleuropneumoniae infections in closed swine herds: infection patterns and serological profiles.Vet Microbiol 85: 343-52, 2002. Chiers K, Donné E, Van Overbeke I, Ducatelle R, andHaesebrouck F. Evaluation of serology,bacteriological isolation and polymerase chain reaction for the detection of pigs carrying Actinobacillus pleuropneumoniae in the upper respiratory tract after experimental infection. Vet Microbiol 88: 385-92, 2002. Chiers K, Haesebrouck F, van Overbeke I, Charlier G, and Ducatelle R. Early in vivo interactions of Actinobacillus pleuropneumoniae with tonsils of pigs. Vet Microbiol 68: 301-306, 1999. Chiers K, Van Overbeke I, Donné E, BaeleM, Ducatelle R, De Baeret, and Haesebrouck F. Detection of Actinobacillus pleuropneumoniae in cultures from nasal and tonsillar swabs of pigs by a PCR assay based on the nucleotide sequence of a dsbE-like gene. Vet Microbial 83(2): 147-159, 2001. Chiu CH, Wu TL, Su LH, Chu CS, Chia JH, Kuo AJ, Chien MS, and Lin TY. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med 346(6): 413-419, 2002. Chiu YT, Lu YP, and Chang IC. Pathologic studies and antimicrobial susceptibility of Salmonella choleraesuis pneumonia in pigs. J Chin Soc Vet Sci 24: 99-108, 1998. Cho WS and Chae C. Genotypic prevalence of apxIV in Actinobacillus pleuropneumoniae field isolates. J Vet Diagn Invest 13: 175-177, 2001. Cruijsen TL, Van Leengoed LA, Dekker-Nooren TC, Schoevers EJ, and Verheijden JH. Phagocytosis and killing of Actinobacillus pleuropneumoniae by alveolar macrophages and polymorphonuclear leukocytes isolated from pigs. Infect Immun 60: 4867-4871, 1992. Davies TA, Goldschmidt R, Pfleger S, Loeloff M, Bush K, Sahm DF, and Evangelista A. Cross-resistance, relatedness and allele analysis of fluoroquinoloneresistant US clinical isolates of Streptococcus pneumoniae (1998–2000). J Antimicrob Chemother 52: 168-175, 2003. Deneer HG and Potter AA. Effect of iron restriction on the outer membrane proteins of Actinobacillus pleuropneumoniae. Infect Immun 57: 798-804, 1989. Desrosiers R. Epidemiology, diagnosis and control of swine diseases. Howard Dunne Memorial Lecture. Proc Am Ass SwineVet 9-37, 2004. Dom P, Haesebrouck F, Kamp EM, and de Baetselier P. Stimulation and suppression of the oxygenation activity of porcine pulmonary alveolar macrophages by Actinobacillus pleuropneumoniae ad its metabolites. Am J Vet Res 53: 1113-1118, 1992. Donabedian SM, Thal LE, Hershberger E, Perri MB, Chow JW, Bartlett P, Jones R, Joyce K, Rossiter S, Gay K, Johnson J, Mackinson C, Debess E , Madden J, Angulo F, and Zervos MJ. Molecular characterization of gentamicin resistant Enterococci in the United States: evidence of spread from animals to humans through food. J Clin Microbiol 41: 1109–1113, 2003. Dreyfus A, Schaller A, Nivollet S, Segers RPAM, Kobisch M, Mieli L, Soerensen V, Hussy D, Miserez R, Zimmerman W, Inderbitzin F, and Frey J. Use of recominant ApxIV in serodiagnosis of Actinobacillus pleuropneumoniae infections, development and prevalidation of the ApxIV ELISA. Vet Microbiol 99: 227-238, 2004. Dritz SS, Chengappa MM, Nelssen JL, Tokach MD, Goodband RD, Nietfeld JC, and Staats JJ. Growth and microbial flora of nonmedicated, segregated, early weaned pigs from a commercial swine operation. J Am Vet Med Assoc 208: 711-715, 1996. D''Silva CG, Archibald FS, and Niven DF. Comparative study of iron acquisition by biotype 1 and biotype 2 strains of Actinobacillus pleuropneumoniae.Vet Microbiol 44:11-23, 1995. Dubreuil JD, Jacques M, Mittal KR, and Gottschalk M. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity. Anim Health Res Rev 1:73-93, 2000. DuPree MR and Wilcox G. Bromotyhmol blue and carbohyfrate-sensitive plating media. J Clin Microbiol 6:343-347, 1997. Fales WH, Morehouse LG, Mittal KR, Bean-Knudsen C, Nelson SL, Kintne LD, Turk JR, Turk MA, Brown TP, and Shaw DP. Antimicrobial susceptibility and serotypes of Actinobacillus(Haemophilus) pleuropneumoniae recovered from Missouri swine. J Vet Diagn Invest 1: 16-19, 1989. Fenwick B, Harris DL, Rider M, and Chengappa M. Serologic validation of the utility of early weaning in preventing sow to piglet transmission of Actinobacillus pleuropneumoniae: production of disease free pigs from infected breeding herds. In: Proceedings of the 14th Intermational Pig Veterinary Society Congress, Bologna, Italy, p.482, 1996. Fenwick BW, Osburn BI, and Olander HJ. Isolaion and biological characterization of two lipopolysaccharides and a capsular-enriched polysaccharide preparation from Haemophilus pleuropneumoniae. Am J Vet Res 47: 1433-1441, 1986. Frey J, Bosse JT, Chang YF, Cullen JM, and Fenwich B, et al. Actinobacillus pleuropneumoniae RTX toxins: uniform desigination of haemolysins, cytolysins, pleurotoxin, and their genes. J Gen Microbiol 139: 1723-1728, 1993. Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol 3: 257-261, 1995. Frost JA, Kelleher A, and Rowe B. Increasing ciprofloxacin resistance in Salmonella in England and Wales 1991-1994. J Antimicrob Chemother 37: 85-91, 1996. Fuller TE, Martin S, Teel JF, Alaniz GR, Kennedy MJ, and Lowery DE. Identification of Actinobacillus pleuropneumoniae virulence genes using signature-tagged mutagenesis in swine infection model. Microb Patho 29: 39-51, 2000. Gagné A, Lacouture S, Broes A, D''allaire S, and Gottschalk M. Development of an immunomagnet ic method for selective isolation of Actinobacillus pleuropneumoniae serotype 1 from tonsils.J Clin Microbiol 36: 251-254, 1998. Gerlach GF, Anderson C , Potter AA, Klashinsky S, and Wilson PJ. Cloning and expression of a transferrin-binding protein form Actinobacillus pleuropneumoniae.Infect Immum 60: 892-898, 1992. Gilbride KA and Rosendal S. Antimicrobial susceptibility of 51 strains Haemophilus pleuropneumoniae. Can J Comp Med 48: 47-50, 1984. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E. Comperative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 43: 2131-2137, 1999. Gonzalez GC, Yu RH, Rosteck PR, and Schryvers AB. Sequence, genetic analysis, and expression of Actinobacillus pleuropneumoniaea transferrin receptor genes. Microbiology 141: 2405-2416, 1995. Gottschalk M and Taylor D. Actinobacillus pleuropneumoniae. Diseases of Swine. Blackwell Publishing, Ames, IA 563-576, 2006. Gottschalk M, Altman E, Charland N, De Lasalle F, and Dubreuil JD. Evaluation of a saline boiled extract, capsular polysaccharides and long-chain lipopolysaccharides of Actinobacillus pleuropneumoniae serotype 1 as antigens for the serodiagnosis of swine pleuropneumoniae. Vet Microbiol 42: 91-104, 1994. Gottschalk M, Altman E, Lacouture S, De Lasalle F, and Dubreuil JD. Serodiagnosis of swine pleuropneumoniae due to Actinobacillus pleuropneumoniae serotypes 7 and 4 using long-chain lipopolysaccharides. Can J Vet Res 61: 62-65, 1997. Gottschalk M, Broes A, Mittal KR, Kobisch M, Kuhnert P, Lebrun A, and Frey J. Non-pathogenic Actinobacillus isolates antigenically and biochemically similar to Actinobacillus pleuropneumoniae: a novel species? Vet Microbiol 92: 87-101, 2003. Gottschalk M, De Lasalle F, Radacovici S, and Dubreuil JD. Evaluation of long chain lipopolysaccharides(LC-LPS) of Actinobacillus pleuropneumoniae serotype 5 for the serodiagnosis of swine pleuropneumoniae. Vet Microbiol 38: 315-327, 1994. Gram T and Ahrens P. Improved diagnostic PCR assay for Actinobacillus pleuropneumoniae based on the nucleotide sequence of an outer membrane lipoprotein. J Clin Microbiol 36: 443-448, 1998. Gram T, Ahrens P, Andreasen M, and Nielsen JP. An Actionbacillus pleuropneumoniae PCR typing system based on the apx and omlA genes—evaluation of isolates from lungs and tonsils of pigs. Vet Microbiol 75: 43-57, 2000. Gram T, Ahrens P, Andreasen M, and Nielsen JP. Evaluation of PCR for detection of Actinobacillus pleuropneumoniae in mixed bacterial cultures from tonsils. Vet Microbiol 5: 95-104, 1996. Grondahl-Hansen J, Barfod K, Klausen J, Andresen LO, Heegaard PMH, and Sorensen V. Development and evaluation of a mixed long-chain lipopolysaccharide based ELISA for serological surveillance of infection with Actinobacillus pleuropneumoniae serotypes 2, 6 and 12 in pig herds. Vet Microbiol 96: 41-51, 2003. Guillemin I, Jarlier V, and Cambau E.Correlation between Quinolone Susceptibility Patterns and Sequences in the A and B Subunits of DNA Gyrase in Mycobacteria. J Antimicrob Chemother 42: 2084-2088, 1998. Gutiérrez CB, Piriz S, Vadillo S, and Rodriguez Ferri EF. In vitro susceptibility of Actinobacillus pleuropneumoniae strains to 42 antimicrobial agents. Am J Vet Res 54: 546-550, 1993. Gutiérrez CB, Rodriguez Barbosa JI, Tascon RI, Costa L, Riera P, and Rodriguez Ferri EF. Serological characterization and antimicrobial susceptibility of Actinobacillus pleuropneumoniae stranis isolated form pigs in Spain. Vet Rec 137: 62-4, 1995. Gutiérrez-Martín CB, del Blanco NG, Blanco M, Navas J, and Rodríguez-Ferri EF. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade. Vet Microbiol.115: 218-22. 2006. Haesebrouck F, Chiers K, Van Overbeke I, and Ducatelle R. Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet Microbiol 58: 239-249, 1997. Hakanen A, Kotilainen P, Jalava J, Siitonen A, and Huovinen P. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 37: 3572-3577, 1999. Harris DL. Isolated weaning. Large Anim Vet 45:10-13, 1990. Heisig P. High-level fluoroquinolone resistance in Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. J Antimicrob Chemother 32:367-377, 1993. Hendriksen RS, Mevius DJ, Schroeter A, Teale C, Jouy E, Butaye P, Franco A, Utinane A, Amado A, Moreno M, Greko C, Stark KD, Berghold C, Myllyniemi AL, Hoszowski A, Sunde M, and Aarestrup FM. Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries from year 2002 – 2004: the ARBAO-II study. Acta Vet Scand. 50:19, 2008. Hennessy KJ, Iandolo JJ, and Fenwick BW. Serotype identification of Actinobacillus pleuropneumoniae by arbitrarily primed polymerase chain reaction. J Clin Microbiol 31: 1155-1159, 1993. Herradora LMA and Martinez-Gamba. Effect of oral enrofloxacin and florfenicol on pigs experimentally infected with Actinobacillus pleuropneumoniae serotype 1. J Vet Med. 50: 259-263, 2003. Hirose K, Hashimoto A, Tamura K, Kawamura Y, Ezaki T, Sagara H, Watanabe H. DNA sequence analysis of DNA gyrase and DNA topoisomerase Ⅳ quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob Agents Chemother 46: 3249-3252, 2002. Hong SS, Huang ST, Chen WL, and Tsai MC. Serotypes and antimicrobial susceptibility of Haemophilus pleuropneumoniae from pigs. J Taiwan Vet Med Anim Hsub 58: 59-67, 1991. Hsu FS. Evaluation of lincospectin sterile solution and LincoSpectin 44 Premix in the treatment of pleuropneumoniae. Proc Int Congr Pig Vet Soc 11: 15, 1990. Hsu SR, Yei CM, Shen YM, and Chou NY. Epidemiology, serovars and antimicrobial susceptibility of swine Haemophilus pleuropneumoniae. Bull Inst Taiwan Sugar Co, pp. 127-132, 1985. Huang TM, Chang YF, and Chang CF. Detection of mutations in the gyrA gene and classⅠintegron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan. Vet Microbiol 100: 247-254, 2004. Inui T, Endo T, and Matsushita T. Morphological changes and lysis induced by beta-lactams associated with the characteristic profiles of affinities of penicillin-binding proteins in Actinobacillus pleuropneumoniae. Antimicrob Agents Chemother 44: 518-23, 2000. Inzana TJ, Glindemann G, Fenwick B, Longstreth J, and Ward D. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.Vet Microbiol 104: 63-71, 2004. Ishii H, Fukuyasu T, Iyobe S, and Hashimoto H. Characteristic of newly isolated plasmids from Actinobacillus pleuropneumoniae. Am J Vet Res 54: 701-8, 1993. Ito H, Ishii H, and Akiba M. Analysis of the complete nucleotide sequence of an Actinobacillus pleuropneumoniae streptomycin-sulfonamide resistance plasmid, pMS260. Plasmid 51: 41-7, 2004. Jacobsen I, Hennig-Pauka I, Baltes N, Trost M, and GerlachGF. Enzymes involed in anaerobic respiration appear to play a role in Actinobacillus pleuropneumoniae. Infect Immun 73: 226-234, 2005. Jacobsen MJ, NielsenJP, and Nielsen R. Comparison of virulence of different Actinobacillus pleuropneumoniae serotypes and biotypes using an aerosol infection model. Vet Microbiol 49: 159-168, 1996. Jacobs-Reitsma WF, Koenraad PMFJ, Bolder NM, and Mulder RWAW. In vitro susceptibility of Campylobacter and Salmonella isolates from broilers to quinolones, ampicillin, tetracycline, and erythromycin. Vet. Q. 16: 206-208, 1994. Jacques M. Surface polysaccharides and iron-uptake systems of Actionbacillus pleuropneumoniae. Can J Vet Res 57: 204-8, 2004. Jansen R, Briaire J, van-Geel AB, Kamp EM, and Gielkens AL, et al. Genetic map of the Actinobacillus pleuropneumoniae RTX-toxin(Apx) operons: characterization of the ApxⅢ operons. Infect Immun 62: 4411-4418, 1994. Jessing SG, Angen Ø, and Inzana TJ. Evaluation of multiplex PCR test for simultaneous identification and serotyping of Antinobacillus pleropneumoniae serotypes 2, 5, and 6. J Clin Microbiol 41: 4095-100, 2003. Kamp EM, Popma JK, and Van Leengoed LAMG. Serotyping of Haemophilus pleuropneumoniae in The Netherlands: with emphasis on heterogeneity within serotype 1 and (proposed) serotype 9. Vet Microbiol 13: 249-257, 1987. Kamp EM, Stockhofe-Zurwieden N, van Leengoed LA, and Smits MA. Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumoniae in pigs. Infect Immun 65: 4350-4354, 1997. Kim B, Min K, Choi C, Cho WS, Cheon DS, Kwon D, Kim J, and Chae C. Antimicrobial susceptibility of Actinabacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures. J Vet Med Sci 63: 341-342, 2001. Klausen J, Andresen LO, Barfod K, and Sørensen V. Evaluation of an enzyme-linked immunosorbent assay for serological surveillance of infection with Actinobacillus pleuropneumoniae serotype 5 in pig herds.Vet Microbiol. 88: 223–232, 2002. Klausen J, Ekeroth L, Grondahl-Hansen J, and Andresen LO . An indirect enzyme-linked immunosorbent assay for detection of antibodies to serovar 7 in pig serum. J Vet Diagn Invest 19: 244-249, 2007. Kobisch M, Vannier P, Delaporte S, and Dellac B. The use of experimental models to study in vivo the antibacterial activity of Enrofloxacin against Actinobacillus (Haemophilus) pleuropneumoniae and Mycoplasma hyopneumoniae in combination with Pasteurella multocida. Proc Int Conger Pig Vet Soc 11: 16, 1990. Krieg NR, Holt JG, Murray RGE, Brenner DJ, Bryant MP, Moulder JW, Pfennig N, Sneath PHA, and Staley JT. Bergey''s mannual of systematic bacteriology. Vol 1. Williams and Wilkins Co. Maryland, USA, 1984. Langford PR, Loynds BM, and Kroll JS. Cloning and molecular characterization of Cu,Zn superoxide dismutase from Actinobacillus pleuropneumoniae. Infect Immun 61: 5035-5041, 1996. Levonen K. The detection of respiratory diseases in swine herds by means of antibody assay on colostrum from sows. Academic Dissertation, Faculty of Veterinary Medicine, University of Helsinki, Helsinky, 2000. Liebana E, Clouting C, Cassar CA, Randall LP, Walker RA, Threlfall EJ, Clifton-Hadley FA, Ridley AM, Davies RH. Comparison of gyrA mutations, cyclohexane resistance, and the presence of classⅠintegrons in Salmonella enterica from farm animals in England and Wales. J Clin Microbiol 40: 1481-1486, 2002. Lo TM. Detection and identificatiom of Actinobacillus pleuropneumoniae serotype 5 by multiplex polymerase chain reaction. Master of Science in Veterinary Medical Sciences. Blacksburg, Virginia, 1997. Lu Z, Zhao P, Shao Y, Liu J, Lu B, et al. Study on the inactivated trivalent vaccine against swine infections pleuropneumoniae: selection of the seed strain, preparation and safety trials of the vaccine. Chin J Vet Sci Tech 37: 33-35. 2002. MacInnes JI, and Rosendal S. Prevention and control of Actinobacillus(Haemophilus) pleuropneumoniae infection in swine: a review. J Can Vet 29: 572-574, 1988. Matter D, Rossano A, Limat S, Vorlet-Fawer L, Brodard I, and PerretnV. Antimicrobial resistance profile of Actinobacillus pleuropneumoniae and Actinobacillus porcitonsillarum. Vet Microbiol. 22: 146-156, 2007. McDonald LC, Chen FJ, Lo HJ, Yin HC, Lu PL, Huang CH, Chen P, Lauderdale TL, and Ho M. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother 45: 3084-3091, 2001. Metiner K, and AK S. Presence and seroprevalence of Actinobacillus pleuropneumoniae in pigs in Turkey. Acta Vet Brno 76: 237-244, 2007. Min K, and Chae C. Detection and distribution of DNA of Actinobacillus pleuropneumoniae in the lungs of naturally infected pogs by in-situ hybridization. J Com Pathol 119: 169-175, 1998. Mittal KR, Higgins R, and Lariviere S. An evaluation of agglutination and coagglutination techniques for serotyping of Haemophilus pleuropneumoniae isolates. Am J Vet Res 48: 219-226, 1987. Mittal KR, Higgins R, Lariviere S, and Leblanc D. A2-mercaptoethanol tube agglutination test for diagnosis of Haemophilus pleuropneumoniae infection in pigs. Am J Vet Res 45: 715-719, 1984. Molbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, Frydendahl K, Gerner-Smiddt P, Petersen AM, and Wegener HC. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med 341(19): 1420-1425, 1999. Moral CH, Soriano AC, Salazar MS, Marcos JY, and Ramos SS. Molecular cloning and sequencing of the aroA gene from Actinobacillus pleuropneumoniae and its use in a PCR Assay for rapid Identification. J Clin Microbiol 37: 1575-1578, 1999. Nadeau M, Lariviére S, Higgins R, and Martineau GP. Minimal inhibitory concentrations of antimicrobial agents against Actinobacillus pleuropneumoniae. Can J Vet Res 52: 315–318, 1988. Narita M, Kawashima K, Morozumi T, and Takashima H. Effect of physical defenses of the respiratory tract on the development of pneumoniae in pigs inoculated endobronchially with Actinobacillus pleuropneumoniae. J Vet Med Sci 57: 839-844, 1995. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals-2nd Edition: Approved Standard M31-A2. NCCLS, Wayne, PA, USA, 2002 Nedbalcova K, Satran P, Jaglic Z, Ondriasova R, and Kucerova Z. Monitoring of antibiotic resistance in isolates of Actinobacillus pleuropneumoniae in the Czech Republic between 2001 and 2003. Vet Med-Czech 50: 181-185, 2005. Nielsen R. Colostral transfer of immunity to Haemophilus parahaemolyticus in pigs. Nord Vet Med 27: 319-328, 1975. Nielsen R. Haemophilus pleuropneumoniae serotypes-cross protection experiments. Nord Vet Med 36: 221-234, 1984. Nielsen R. Serological characterization of Haemophilus pleuropneumoniae (Actinobacillus pleuropneumoniae) strains and proposal of a new serotype: serotype 9. Acta Vet Scand 26: 501-512, 1985. Nielsen R. Serological characterization of Actinobacillus pleuropneumoniae strains and proposal of a new serotype: serotype12. Acta Vet Scand 27: 453-455, 1986. Nielsen R. Serological characterization of Haemophilus pleuropneumoniae (Actinobacillus pleuropneumoniae) strains and proposal of a new serotype: serotype 10. Acta Vet Scand 26: 581-586, 1986. Nielsen R. Detection of antibodies against Actinobacillus pleuropneumoniae, serotype 2 in porcine colostrum using a blocking enzyme-linked immunosorbent assay specific for serotype 2. Vet Microbiol 43: 277-281, 1995. Niven DF, Donga J, and Archibald FS. Responses of Haemophilus pleuropneumoniae to iron restriction: changes in the outer membrane protein profile and the removal of iron porcine transferrin. Mol Microbiol 3: 1083-1089, 1989. Paradis MA, Vessie GH, Merrill JK, Dick CP, Moore C, Charbonneau G, Gottschalk M, MacInnes JI, Higgins R, Mittal KR, Girard C, Aramini JJ, and Wilson JB. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine. Can J Vet Res 68: 7-11, 2004. Paradis SE, Dubreuil JD, Gottschalk M, Archambault M, and Jacques M. Inhibition of adherence of Actinobacillus pleuropneumoniae to porcine respiratory tract cells by monoclonal antibodies directed against LPS and partial characterization of the LPS receptors. Curr Microbiol 39: 313-320, 1999. Perry MB, Altman E, Brisso JR, Beynon LM, and Richard JC. Structural characteristics of the antigenic capsular polysaccharides and lipopolysaccharides involed in the serological classification of Actinobacillus (Haemophilus) pleuropneumoniae strains. Serodiagn. Immunol Inf Dis 4: 299-308, 1990. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58: 11-18, 1999. Piddock LJV. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol, Rev. 26: 3-16, 2002. Quinn PJ, Carter ME, Markey B, and Carter GR. Clinical Veterinary Microbiology. 398-400, 1994. Radacovici S, Gottschalk M, and Dubreuil JD. Lipopolysaccharides of Actinobacillus pleuropneumoniae(serotype 1): a readily obtainable antigen for ELISA serodiagnosis of pig pleuropneumoniae. Vet Microbiol 39: 219-230, 1994. Radacovici S, Gottschalk M, and Dubreuil JD. Recovery of long-chain lipopolysaccharides from liquid culture of Actinobacillus pleuropneumoniae(serotype 5) for ELISA serodiagnosis. Vet Res 26: 63-67, 1995. Reche MP, Garcia de los Rios JE, Jimenez PA, Rojas AM, Rotger R. gyrA mutations associated with nalidixic acid-resistant Salmonellae from wild birds. Antimicrob Agents Chemother 46: 3108-3109, 2002. Rioux S, Galarneau C, Harel J, Kobisch M, Frey J, Gottschalk M, and Jacques M. Isolation and characterization of a capsule-deficient muatnt of Actinobacillus pleuropneumoniae serotype 1. Microb Pathog 28: 279-289, 2000. Rodriguez-Barbosa JI, Gutierrez CB, Tascon RI Suarez J, Noronia Fed, and Rodriguez-Ferri EF. Characterization of monoclonal antibodies to O antigen of lipopolysaccharide of Actinobacillus pleuropneumoniae serotype 2 and their use in the classification of field isolates. FEMS Immunol and Med Micro 11: 35-44, 1995. Rosendal S, and Boyd DA. Haemophilus pleuropneumoniae serotyping. J Clin Microbiol 16: 840-843, 1982. Sakpuaram T, Fukuyasu T, and Ashida K. Isolation if Actinobacillus pleuropneumoniae from pneumonic lungs of slaughtered pigs. Jpn J Vet Sci 51: 1279-1281, 1989. Salmon SA, Watts JL, Case CA, et al. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada and Denmark. J Clin Microbiol 33: 2435–2444, 1995. Salyers AA and Whitt DD. Bacterial pathogenesis: a molocular approach Washington, D.C.: ASM Press, 1994 Sande M and Chambers H. Antimicrobial agenets, general considerations. Section IX, Chemotherapy of microbial diseases. In: Hardman J, Limbird L, Molinoff P, et al. (ed.). Goodman and Gilmans’s the Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill, New York, 1996. Satran P and Nedbalcova K. Prevalence of serotypes, production of Apx toxins, and antibiotic resistance in strains of Actinobacillus pleuropneumoniae isolated in the Czech Republic. Vet Med 47: 92-98, 2002. Schaller A, Djordjevic SP, Eamens GJ, Forbes WA, Kuhn R, Kuhert P, Gottschalk M, Nicolet J, and Frey J. Identification and detection of Actinobacillus pleuropneumoniae by PCR based on the gene apxⅣA. Vet Microbiol 79: 47-62, 2001. Schaller A, Kuhn R, Kuhnert P, Nicolet J, Anderson TJ, MacInnes JI, Seger RPAM, and Frey J. Characterization of apxⅣA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology 8: 2105-2116, 1999. Schuchert JA, Inzana TJ, Angen Ø, and Jessing S. Detection and identification of Actinobacillus pleuropneumoniae serotypes1, 2, and 8 by multiplex PCR. J Clin Microbiol 42: 4344-8, 2004. Sebunya TN and Saunders JR. Haemophilus pleuropneumoniae infection in swine: a review. J Am Vet Med Assoc 182: 1331-1337, 1983. Sergio M, Javier SC, Iqnasi B, Jordi V, and Ernest G. Mechanism of Binding of Fluoroquinolones to the Quinolone Resistance-Determining Region of DNA Gyrase: Towards an Understanding of the Molecular Basis of Quinolone Resistance. Chembiocherm 13: 2081-2086, 2008. Sheehan BJ, Bosse JT, Beddek AJ, Rycroft AN, Kroll JS, and Langford PR. Identification of Actinobacillus pleuropneumoniae genes important for survival during infection in its natural host. Infect Immun 71: 4124-4132, 2003. Shin SJ, Kang SG, Nabin R, Kang ML, Yoo HS. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease.Vet Microbiol 106: 73–77, 2005. Sibille Y and Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141: 471-501, 1990. Sidibe M, Messier S, Lariviere S, Gottschalk M, and Mittal KR. Detection of Actinobacillus pleuropneumoniae in the porcine upper respiratory tract as a complement to serological tests. Can J Vet Res 57:
摘要: 
Actinobacillus pleuropneumoniae(APP) 是豬隻重要的地方流行性呼吸道疾病,造成養豬產業重大經濟損失。本研究於2007年7月至2008年7月於彰化地區養豬場採集疑似APP症狀之豬隻肺臟,共計分離56株APP,以快速平板凝集試驗法及PCR進行血清型分型結果為︰1型44株(79 %)、2型3株(5 %)、5型3株(5 %)、7型2株(4 %)、8型4株(7 %),目前台灣流行的APP血清型仍以第1型為主。以紙錠擴散法進行21種抗菌劑感受性試驗,結果顯示96%之分離株對5種以上之抗生素具有抗藥性,各藥對APP抗藥性比率以streptomycin (98 %)、oxytetracycline(93 %)為最高;敏感性方面,則以ceftiofur (98 %)、colistin(68 %)、florocol (61 %)、chloramphenicol (61 %)有效比例較高。另外,比較同一養豬場中,分離到的APP與腸內菌科細菌(沙門氏菌及大腸桿菌)之抗藥性數量,並無顯著差異(p>0.05)。本研究中,設計四對引子對以PCR法檢測APP之gyrA、gyrB、parC、parE基因之QRDRs(Quinolone Resistance Determining Regions)中的點突變,探討QRDRs突變與APP對quinolone抗菌劑產生抗藥性的關聯,結果顯示對quinolone具抵抗性的APP菌株,在gyrA基因的第83個氨基酸(Ser-83-to- Phe or Val or Tyr)或第87個氨基酸(Asp-87-to- His or Asn or Tyr)具有單一點突變;而對fluoroquinolone具抵抗性之菌株則在第83個氨基酸和第87個氨基酸具有雙重點突變(Ser-83-to-Phe and Asp-87-to-Gly, Ser-83-to-Phe and Asp-87-to-Asn, Ser-83-to-Phe and Asp-87-to-Tyr)。實驗結果顯示目前在台灣的養豬業,APP與腸內菌科已產生多重抗藥性,且APP菌株與已知腸內菌科細菌具有相似的QRDRs突變模式,因抗藥性基因可能在不同菌種間傳播,抗藥性的形成不僅會影響畜牧業的經濟效益,當抗藥性基因傳遞到人畜共通的細菌時,將嚴重影響人體健康,形成公共衛生學的威脅,因此,必需在養豬業建立一套監測系統以監控多重抗藥性菌株的出現,畜禽業抗菌劑的使用也應受到嚴格的限制與管控。

Actinobacillus pleuropneumoniae (APP) causes porcine pleuropneumoniae, a worldwide disease of swine that results in severe economic losses. A total of 56 strains of APP were isolated from the lungs of pigs that died of pleuropneumoniae from farms in Changhua county during July 2007 and July 2008. Of the 56 APP serotyped by a rapid slide agglutination test and PCR , 44 isolates (79 %) were of serotype1; 3 each (5 %) were of serotype 2, 5; 2 (4 %) were of serotype 7; and 4 (7%) were of serotype 8. Serotype 1 was still the most prevalent in Taiwan. The isolates were tested for their susceptibility to 21 antimicrobials using an agar disk diffusion method. Ninety-six percent of the isolates were resistant to at least five antimicrobials. A high rate of resistance was observed to streptomycin (98 %) and oxytetracycline (93 %). Higher rate of susceptibility was observed to ceftiofur (98 %), colistin (68 %), florocol (61 %) and chloramphenicol (61 %). When comparing the resistant numbers of antimicrobials, there was no significantly difference (p>0.05) between APP and genus of Enterobacteraceae (Salmonella and E. coli) recovered from the same farm. In order to identify QRDRs (Quinolone Resistance Determining Regions) mutations in quinolone-resistant isolates of APP, we designed four pairs of primers to amplify the QRDRs genes of gyrA, gyrB, parC, parE and sequenced. It appears that that one mutation in the QRDRs of gyrA, leading to amino acid changes in either codon 83 (Ser-83-to- Phe or Val or Tyr) or codon 87 (Asp-87-to- His or Asn or Tyr), contribute to the resistance of quinolone. Instead, strains carried double mutations in both codon 83 and 87 (Ser-83-to-Phe and Asp-87-to-Gly, Ser-83-to-Phe and Asp-87-to-Asn, Ser-83-to-Phe and Asp-87-to-Tyr) become FQ-resistant. This study demonstrates that APP and genus of Enterobacteraceae were resistant to multidrugs in Taiwan. Similar mutation patterns of QRDRs were also observed in APP as genus of Enterobacteraceae in previous works. The widespread use of antibiotics for treatment of pleuropneumonia in swine may lead to selective survival of strains with resistant genes that can be transformed to other zoonotic bacteria which may be hazards for animal health and public health. Thus, use of antibiotics must be cautiously approached and a surveillance system is indispensable for the swine industry to monitor the multidrug resistant bacterial pathogens in Taiwan.
URI: http://hdl.handle.net/11455/66359
其他識別: U0005-2201200912235500
Appears in Collections:微生物暨公共衛生學研究所

Show full item record
 

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.